Nutrients,
Journal Year:
2023,
Volume and Issue:
15(3), P. 740 - 740
Published: Feb. 1, 2023
Approximately
7%
of
cancers
arising
in
children
and
1%
those
adults
are
soft
tissue
sarcomas
(STS).
Of
these
malignancies,
rhabdomyosarcoma
(RMS)
is
the
most
common.
RMS
survival
rates
using
current
therapeutic
protocols
have
remained
largely
unchanged
past
decade.
Thus,
it
imperative
that
main
molecular
drivers
tumorigenesis
defined
so
more
precise,
effective,
less
toxic
therapies
can
be
designed.
Curcumin,
a
common
herbal
supplement
derived
from
plants
Curcuma
longa
species,
has
an
exceptionally
low
dietary
biotoxicity
profile
demonstrated
anti-tumorigenic
benefits
vitro.
In
this
study,
activity
curcumin
was
assessed
cell
lines
used
to
identify
major
pathways
responsible
for
curcumin's
effects.
Curcumin
treatment
resulted
cycle
arrest,
inhibited
migration
colony
forming
potential,
induced
apoptotic
death.
Proteome
profiler
array
analysis
primarily
influenced
flux
through
AKT-mammalian
target
rapamycin
(mTOR),
signal
transducer
activator
transcription
(STAT),
AMP-dependent
kinase
(AMPK),
p53
associated
subtype-specific
manner.
strategic,
combinational
targeting
may
present
best
option
treat
group
tumors.
Journal of Cancer Metastasis and Treatment,
Journal Year:
2020,
Volume and Issue:
2020
Published: Aug. 21, 2020
Aberrant
activation
of
signal
transducer
and
activator
transcription
(STAT)
proteins
is
associated
with
the
development
progression
solid
tumors.
However,
as
factors,
these
are
difficult
to
target
directly.
In
this
review,
we
summarize
role
targeting
Janus
kinases
(JAKs),
upstream
activators
STATs,
a
strategy
for
decreasing
STAT
in
Preclinical
studies
tumor
cell
line
models
show
that
JAK
inhibitors
decrease
activation,
proliferation,
survival;
Frontiers in Pharmacology,
Journal Year:
2021,
Volume and Issue:
12
Published: Nov. 15, 2021
Receptor
tyrosine
kinases
(RTKs)
are
transmembrane
cell-surface
proteins
that
act
as
signal
transducers.
They
regulate
essential
cellular
processes
like
proliferation,
apoptosis,
differentiation
and
metabolism.
RTK
alteration
occurs
in
a
broad
spectrum
of
cancers,
emphasising
its
crucial
role
cancer
progression
suitable
therapeutic
target.
The
use
small
molecule
inhibitors
however,
has
been
crippled
by
the
emergence
resistance,
highlighting
need
for
pleiotropic
anti-cancer
agent
can
replace
or
be
used
combination
with
existing
pharmacological
agents
to
enhance
treatment
efficacy.
Curcumin
is
an
attractive
mainly
due
potent
effects,
extensive
range
targets
minimal
toxicity.
Out
numerous
documented
curcumin,
RTKs
appear
one
main
nodes
curcumin-mediated
inhibition.
Many
studies
have
found
curcumin
influences
activation
their
downstream
signaling
pathways
resulting
increased
decreased
proliferation
migration
both
vitro
vivo.
This
review
focused
on
how
exhibits
effects
through
inhibition
MAPK,
PI3K/Akt,
JAK/STAT,
NF-κB
pathways.
Combination
were
also
analysed
emphasis
common
molecular
targets.
Frontiers in Cell and Developmental Biology,
Journal Year:
2020,
Volume and Issue:
8
Published: Aug. 26, 2020
Circulating
tumor
cells
(CTCs)
are
accessible
by
liquid
biopsies
via
an
easy
blood
draw.
They
represent
not
only
the
primary
site,
but
also
potential
metastatic
lesions,
and
could
thus
be
attractive
supplement
for
cancer
diagnostics.
However,
analysis
of
rare
CTCs
in
billions
normal
is
still
technically
challenging
novel
specific
CTC
markers
needed.
The
formation
metastasis
a
complex
process
supported
numerous
molecular
alterations,
might
found
focusing
on
this
process.
One
example
changes
cell
glycocalyx,
which
network
surface
composed
carbohydrate
structures.
Proteoglycans
important
glycocalyx
components
consist
protein
core
covalently
attached
long
glycosaminoglycan
chains.
A
few
assays
have
already
utilized
proteoglycans
both
enrichment
CTCs.
biological
function
clinical
has
been
studied
detail
so
far.
Therefore,
present
review
describes
proteoglycan
functions
during
cascade
to
highlight
their
importance
We
outline
current
approaches
based
targeting
cores
or
Lastly,
we
briefly
discuss
technical
aspects,
should
considered
studying
proteoglycans.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(18), P. 4685 - 4685
Published: Sept. 18, 2021
Prolactin
receptor
(PRLR)
and
epidermal
growth
factor
(EGFR/ERBB)
signaling
pathways
activated
by
prolactin
(PRL)
(EGF),
have
a
major
role
in
the
mammary
gland
development
etiology
of
breast
cancer,
respectively.
ER+
tumors
comprise
up
to
75%
all
cancers
10%
these
are
HER2+.
Elevated
levels
PRLR
tumors,
high
circulating
PRL
increased
expression
ERBB1/2
patients
that
become
resistant
endocrine
therapy
shown
be
associated
with
higher
risk
cancer
progression.
In
this
review,
we
examine
crosstalk
between
activation
unliganded
ERα,
cyclin-D1
other
oncogenic
factors
(MYC,
FOS,
JUN)
cancer.
PRL/PRLR
EGF/EGFR
induces
phosphorylation
ERα
through
MEK/MAPK
PI3K/AKT
pathways.
cells
via
PRLR/JAK2
can
also
induce
ERBB2/HER2,
which
turn
activates
downstream
RAS/MEK/ERK
pathway
required
for
phosphorylation.
EGFR,
independent
PRL/PRLR,
activate
STAT5
indirectly
c-SRC
drive
target
genes
involved
cell
proliferation
survival.
The
HER2,
where
HER2
an
alternative
route
transcription
ER
genes.
We
believe
overexpression
EGFR/HER2
could
maximize
actions
their
ligands,
further
promoting
malignancy.
This
explain
resistance
resulting
tumor
growth.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(4), P. 1701 - 1701
Published: Feb. 8, 2021
The
significance
of
glutamine
in
cancer
metabolism
has
been
extensively
studied.
Cancer
cells
consume
an
excessive
amount
to
facilitate
rapid
proliferation.
Thus,
depletion
occurs
various
types,
especially
poorly
vascularized
cancers.
This
makes
synthetase
(GS),
the
only
enzyme
responsible
for
de
novo
synthesizing
glutamine,
essential
metabolism.
In
cancer,
GS
exhibits
pro-tumoral
features
by
supporting
nucleotide
synthesis.
Furthermore,
is
highly
expressed
tumor
microenvironment
(TME)
and
provides
cells,
allowing
maintain
sufficient
level
catabolism.
Glutamine
catabolism,
opposite
reaction
synthesis
GS,
well
known
cell
proliferation
via
contributing
biosynthesis
molecules
energy
production.
Either
anabolism
or
catabolism
a
critical
function
depending
on
complex
nature
this
review,
we
focus
role
variety
types
microenvironments
highlight
mechanism
at
transcriptional
post-translational
levels.
Lastly,
discuss
therapeutic
implications
targeting
cancer.
Breast Cancer Research,
Journal Year:
2023,
Volume and Issue:
25(1)
Published: March 7, 2023
Abstract
Background
Higher
circulating
prolactin
has
been
associated
with
increased
breast
cancer
risk.
Prolactin
binding
to
the
receptor
(PRLR)
can
activate
transcription
factor
STAT5,
thus,
we
examined
association
between
plasma
and
risk
by
tumor
expression
of
PRLR,
upstream
kinase
JAK2.
Methods
Using
data
from
745
cases
2454
matched
controls
in
Nurses’
Health
Study,
conducted
polytomous
logistic
regression
examine
(>
11
ng/mL
vs.
≤
ng/mL)
measured
within
10
years
diagnosis
PRLR
(nuclear
[N],
cytoplasmic
[C]),
phosphorylated
STAT5
(pSTAT5;
N,
C),
JAK2
(pJAK2;
C)
expression.
Analyses
were
separately
premenopausal
(
n
=
168
cases,
765
controls)
postmenopausal
women
577
1689
controls).
Results
In
women,
levels
>
positively
tumors
positive
for
pSTAT5-N
(OR
2.30,
95%
CI
1.02–5.22)
pSTAT5-C
1.64,
1.01–2.65),
but
not
that
negative
these
markers
0.98,
0.65–1.46
OR
0.73,
0.43–1.25;
p-heterogeneity
0.06
0.02,
respectively).
This
was
stronger
when
both
2.88,
1.14–7.25).
No
observed
or
pJAK2
(positive
negative)
among
women.
Among
irrespective
pSTAT5,
(all
≥
0.21).
Conclusion
We
did
observe
clear
differences
pJAK2,
although
associations
pSTAT5
only.
While
additional
studies
are
needed,
this
suggests
may
act
on
human
development
through
alternative
pathways.